Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Tong Ren Tang Technologies Co ( (HK:1666) ) has issued an announcement.
Tong Ren Tang Technologies Co. Ltd. announced the interim financial results of its subsidiary, Tong Ren Tang Chinese Medicine, for the first half of 2025. The subsidiary reported a revenue increase to HK$761,736,000, up from HK$664,518,000 in the same period in 2024, with a profit for the period of HK$245,936,000. This financial performance highlights the company’s strong market position and potential growth in the traditional Chinese medicine sector.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. operates in the traditional Chinese medicine industry, focusing on the production and distribution of Chinese medicinal products. The company is known for its extensive range of herbal medicines and health products, catering to both domestic and international markets.
Average Trading Volume: 1,501,746
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.89B
For an in-depth examination of 1666 stock, go to TipRanks’ Overview page.